A health system-wide opioid stewardship program may have a positive influence on opioid prescribing habits after orthopedic surgery.
CNTX-6016, a highly-selective cannabinoid receptor type 2 agonist, was found to provide adequate analgesia in preclinical models of neuropathic pain.
Lofexidine may effectively mitigate the symptoms of opioid withdrawal in patients on long-term opioid therapy for chronic pain.
Prescription drug monitoring programs may reduce the overall opioid prescribing rate in emergency departments.
Canadian researchers are examining the potential for immersive virtual reality to provide prolonged analgesia in patients with chronic pain.
Ketamine infusion therapy may not effectively reduce opioid consumption in patients with rib fractures as a result of blunt chest trauma.
Patients with chronic pain may perceive improvements in pain, sleep, anxiety, and depression with the use of hemp-derived cannabidiol oil.
A group-based cognitive behavioral therapy intervention may improve pain-related acceptance in veterans with chronic pain.
An interdisciplinary work group has developed new guidelines for inpatient pain management that was perceived as helpful by clinicians.
Researchers are developing a consensus report to provide clinical guidance for the management of patients with chronic non cancer pain who are taking both opioids and cannabinoids.